No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ALLK Allakos
- 1.100
- +0.080+7.84%
Close Apr 29 16:00 ET
- 1.100
- 0.0000.00%
Post 16:01 ET
97.40MMarket Cap-514P/E (TTM)
1.140High1.020Low604.18KVolume1.030Open1.020Pre Close651.63KTurnover1.03%Turnover RatioLossP/E (Static)88.54MShares5.64052wk High0.58P/B64.65MFloat Cap0.98052wk Low--Dividend TTM58.78MShs Float157.980Historical High--Div YieldTTM11.77%Amplitude0.980Historical Low1.078Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Market Outperform Rating Reiterated for Allakos Amid Promising AK006 Clinical Developments
Hold Rating on Allakos Amidst Cautious Optimism for AK006 Program
Allakos Inc (ALLK) Reports Increased R&D Expenses and Net Loss in Q4
Hold Rating on Allakos Amidst Clinical Pivots and Prospective AK006 Developments
Analysts Are Bullish on These Healthcare Stocks: Allakos (ALLK), Century Therapeutics (IPSC)
Analysts Conflicted on These Healthcare Names: Allogene Therapeutics (ALLO), Aquestive Therapeutics (AQST) and Allakos (ALLK)
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg